source
- TROP2 scoring and MTAP loss emerge as key biomarkers for NSCLC treatment decisionsResearchers are highlighting two molecular features-TROP2 expression and loss of the MTAP enzyme-as potential guides for therapy in non‑small cell lung cancer. Quantitative scoring of TROP2 by pat…
- Dr. Hunter outlines anemia treatment options for myelofibrosis patientsDr. Anthony M. Hunter, a hematology specialist, discussed how clinicians approach anemia in patients with myelofibrosis. He highlighted luspatercept as one therapeutic option, noting its mechanism…